Patient Derived Xenograft/PDX Models Market Size, Share, Growth, and Industry Analysis, By Types (Mice Models, Rat Models, ), By Applications (Pre-clinical Drug Development and Basic Cancer Research, Biomarker Analysis, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Patient Derived Xenograft/PDX Models Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Patient Derived Xenograft/PDX Models Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Patient Derived Xenograft/PDX Models Business Mode and Production Process

2.3.1 Patient Derived Xenograft/PDX Models Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Patient Derived Xenograft/PDX Models Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Patient Derived Xenograft/PDX Models

2.4.2 Raw Material Cost of Patient Derived Xenograft/PDX Models

2.4.3 Labor Cost of Patient Derived Xenograft/PDX Models

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Patient Derived Xenograft/PDX Models Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Patient Derived Xenograft/PDX Models Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Patient Derived Xenograft/PDX Models Price by Manufacturer (2021-2026)

4.4 Patient Derived Xenograft/PDX Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Patient Derived Xenograft/PDX Models, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Patient Derived Xenograft/PDX Models, Product Offered and Application

4.7 Patient Derived Xenograft/PDX Models Market Competitive Situation and Trends

4.7.1 Patient Derived Xenograft/PDX Models Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Patient Derived Xenograft/PDX Models Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Patient Derived Xenograft/PDX Models Market Historical Development by Geographic Region (2021-2026)

5.1 Global Patient Derived Xenograft/PDX Models Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Patient Derived Xenograft/PDX Models Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Patient Derived Xenograft/PDX Models Market Status by Country (2021-2026)

5.3.1 North America Patient Derived Xenograft/PDX Models Sales Volume by Country (2021-2026)

5.3.2 North America Patient Derived Xenograft/PDX Models Revenue by Country (2021-2026)

5.3.3 United States Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Patient Derived Xenograft/PDX Models Market Status by Country (2021-2026)

5.4.1 Europe Patient Derived Xenograft/PDX Models Sales Volume by Country (2021-2026)

5.4.2 Europe Patient Derived Xenograft/PDX Models Revenue by Country (2021-2026)

5.4.3 Germany Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Patient Derived Xenograft/PDX Models Market Status by Country (2021-2026)

5.5.1 Asia Pacific Patient Derived Xenograft/PDX Models Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Patient Derived Xenograft/PDX Models Revenue by Country (2021-2026)

5.5.3 China Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Patient Derived Xenograft/PDX Models Market Status by Country (2021-2026)

5.6.1 Latin America Patient Derived Xenograft/PDX Models Sales Volume by Country (2021-2026)

5.6.2 Latin America Patient Derived Xenograft/PDX Models Revenue by Country (2021-2026)

5.6.3 Mexico Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Patient Derived Xenograft/PDX Models Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Patient Derived Xenograft/PDX Models Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Patient Derived Xenograft/PDX Models Revenue by Country (2021-2026)

5.7.3 GCC Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Patient Derived Xenograft/PDX Models Sales Volume, Revenue and Growth (2021-2026)



6 Global Patient Derived Xenograft/PDX Models Market Historical Development by Product Type (2021-2026)

6.1 Patient Derived Xenograft/PDX Models Definition by Type

6.2 Global Patient Derived Xenograft/PDX Models Historical Sales Volume by Product Type (2021-2026)

6.3 Global Patient Derived Xenograft/PDX Models Historical Revenue by Product Type (2021-2026)

6.4 Global Patient Derived Xenograft/PDX Models Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Patient Derived Xenograft/PDX Models Historical Sales Volume, Revenue and Growth Rate of Mice Models (2021-2026)
6.5.2 Global Patient Derived Xenograft/PDX Models Historical Sales Volume, Revenue and Growth Rate of Rat Models (2021-2026)


7 Global Patient Derived Xenograft/PDX Models Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Patient Derived Xenograft/PDX Models Historical Sales Volume by End User (2021-2026)

7.3 Global Patient Derived Xenograft/PDX Models Historical Revenue by End User (2021-2026)

7.4 Global Patient Derived Xenograft/PDX Models Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Patient Derived Xenograft/PDX Models Historical Sales Volume, Revenue and Growth Rate of Pre-clinical Drug Development and Basic Cancer Research (2021-2026)
7.5.2 Global Patient Derived Xenograft/PDX Models Historical Sales Volume, Revenue and Growth Rate of Biomarker Analysis (2021-2026)


8 Leading Companies Profiles

8.1 Champions Oncology
8.1.1 Champions Oncology Corporation Information
8.1.2 Champions Oncology - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.1.3 Champions Oncology Performance Analysis (2021-2026)
8.1.4 Champions Oncology Business and Markets Served
8.1.5 Champions Oncology Recent Developments
8.2 The Jackson Laboratory
8.2.1 The Jackson Laboratory Corporation Information
8.2.2 The Jackson Laboratory - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.2.3 The Jackson Laboratory Performance Analysis (2021-2026)
8.2.4 The Jackson Laboratory Business and Markets Served
8.2.5 The Jackson Laboratory Recent Developments
8.3 Crown Bioscience
8.3.1 Crown Bioscience Corporation Information
8.3.2 Crown Bioscience - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.3.3 Crown Bioscience Performance Analysis (2021-2026)
8.3.4 Crown Bioscience Business and Markets Served
8.3.5 Crown Bioscience Recent Developments
8.4 Pharmatest Services
8.4.1 Pharmatest Services Corporation Information
8.4.2 Pharmatest Services - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.4.3 Pharmatest Services Performance Analysis (2021-2026)
8.4.4 Pharmatest Services Business and Markets Served
8.4.5 Pharmatest Services Recent Developments
8.5 Oncodesign
8.5.1 Oncodesign Corporation Information
8.5.2 Oncodesign - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.5.3 Oncodesign Performance Analysis (2021-2026)
8.5.4 Oncodesign Business and Markets Served
8.5.5 Oncodesign Recent Developments
8.6 Urolead
8.6.1 Urolead Corporation Information
8.6.2 Urolead - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.6.3 Urolead Performance Analysis (2021-2026)
8.6.4 Urolead Business and Markets Served
8.6.5 Urolead Recent Developments
8.7 Xentech
8.7.1 Xentech Corporation Information
8.7.2 Xentech - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.7.3 Xentech Performance Analysis (2021-2026)
8.7.4 Xentech Business and Markets Served
8.7.5 Xentech Recent Developments
8.8 Charles River Laboratories
8.8.1 Charles River Laboratories Corporation Information
8.8.2 Charles River Laboratories - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.8.3 Charles River Laboratories Performance Analysis (2021-2026)
8.8.4 Charles River Laboratories Business and Markets Served
8.8.5 Charles River Laboratories Recent Developments
8.9 Horizon Discovery
8.9.1 Horizon Discovery Corporation Information
8.9.2 Horizon Discovery - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.9.3 Horizon Discovery Performance Analysis (2021-2026)
8.9.4 Horizon Discovery Business and Markets Served
8.9.5 Horizon Discovery Recent Developments
8.10 WuXi Apptec
8.10.1 WuXi Apptec Corporation Information
8.10.2 WuXi Apptec - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.10.3 WuXi Apptec Performance Analysis (2021-2026)
8.10.4 WuXi Apptec Business and Markets Served
8.10.5 WuXi Apptec Recent Developments
8.11 Hera Biolabs
8.11.1 Hera Biolabs Corporation Information
8.11.2 Hera Biolabs - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.11.3 Hera Biolabs Performance Analysis (2021-2026)
8.11.4 Hera Biolabs Business and Markets Served
8.11.5 Hera Biolabs Recent Developments
8.12 EPO Berlin-Buch
8.12.1 EPO Berlin-Buch Corporation Information
8.12.2 EPO Berlin-Buch - Patient Derived Xenograft/PDX Models Product Portfolio and Specification
8.12.3 EPO Berlin-Buch Performance Analysis (2021-2026)
8.12.4 EPO Berlin-Buch Business and Markets Served
8.12.5 EPO Berlin-Buch Recent Developments


9 Global Patient Derived Xenograft/PDX Models Market Forecast by Product Type and End User (2026-2034)

9.1 Global Patient Derived Xenograft/PDX Models Market Forecast by Product Type (2026-2034)

9.1.1 Global Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth Rate of Mice Models (2026-2034)
9.1.2 Global Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth Rate of Rat Models (2026-2034)
9.2 Global Patient Derived Xenograft/PDX Models Market Forecast by End User (2026-2034)

9.2.1 Global Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth Rate of Pre-clinical Drug Development and Basic Cancer Research (2026-2034)
9.2.2 Global Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth Rate of Biomarker Analysis (2026-2034)


10 Global Patient Derived Xenograft/PDX Models Market Forecast by Geographic Region (2026-2034)

10.1 Global Patient Derived Xenograft/PDX Models Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Patient Derived Xenograft/PDX Models Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer